China NMPA Drug Inspection - Gansu Xuanyuan Pharmaceutical Development Co., Ltd. - Cynomorium
China NMPA drug inspection for Gansu Xuanyuan Pharmaceutical Development Co., Ltd. published December 30, 2019. Drug: Cynomorium. The Gansu Provincial Drug Administration issued a Drug Quality Announcement on December 30, 2019, identifying significan
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Gansu Xuanyuan Pharmaceutical Development Co., Ltd. published December 30, 2019. Drug: Cynomorium. The Gansu Provincial Drug Administration issued a Drug Quality Announcement on December 30, 2019, identifying significan
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox